Qiagen

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

1 Stories Indexed

Last Updated: Just Now

Verified Entity Intelligence

Global Markets & Equities 22 Oct 2026, 05:00 PM IST

EQT Agrees to Buy Qiagen in $10.8 Billion All-Cash Takeover

EQT has agreed to acquire German molecular testing company Qiagen in an all-cash deal valued at about $10.8 billion, marking one of the largest healthcare buyouts in Europe this year. The transaction underscores private equity’s continued appetite for stable, cash-generative life sciences assets even as higher rates and volatile markets complicate dealmaking.

By RDU Global Wire5 min read

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Qiagen:

Washington, D.C.(1)EQT(1)